Janssen-cilag Ltd.
Clinical trials sponsored by Janssen-cilag Ltd., explained in plain language.
A pharmaceutical company, subsidiary of Johnson & Johnson.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New study tracks arthritis drug persistence in daily life
Disease control Recruiting nowThis study follows 200 adults with psoriatic arthritis who are starting guselkumab as part of their normal care. Researchers will track how many patients continue the treatment after one and two years, and why some stop. The goal is to understand how well the drug works in real-w…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Real-World check: does new IBD drug guselkumab deliver in the clinic?
Disease control Recruiting nowThis study tracks 220 adults with moderate-to-severe ulcerative colitis or Crohn's disease who are starting guselkumab, a biologic drug. Researchers will measure how many achieve remission (symptom control) and whether they can stop steroids. The goal is to see how well the drug …
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Real-World data on new myeloma drugs: how well do they work outside trials?
Knowledge-focused Recruiting nowThis study collects information from about 900 people with relapsed/refractory multiple myeloma who received teclistamab or talquetamab in regular medical practice, not in a clinical trial. Researchers will look at how well the drugs work, how long benefits last, and what side ef…
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC